CS Paper Radar

Enhancing Clinical Classifier Robustness with Deep Representation Learning Based OOD Detection on DNA Methylation Data

Md Zahangir Alom, Quynh T. Tran, Breuer Alexandar, Brent A. Orr

cs.AI q-bio.GNcs.LG ·submitted 2026-10-26 22:11 UTC · v1

Abstract

DNA methylation (DNAM) array-based tumor classification is a powerful clinical diagnostic tool, but models trained on fixed reference cohorts can produce faulty predictions for tumor types not represented in the training distribution. We propose an end-to-end deep representation learning-based out-of-distribution (OOD) detection framework for DNAm array data. Deep neural network (DNN) classifiers were trained on public sarcoma (SARC) (GSE140686) and brain tumor (BT) (GSE90496) cohorts, and feature vectors were extracted from bottleneck layers. Five OOD methods, including 1dimension (1D)-Subspace Analysis (1D-SSA), K-Nearest Neighbors (KNN), Ridge Regression, Mahalanobis Distance (MD), and Sum of Squared Distances (SSD), were explored with 200 and 500-dimensional embeddings. Spectral discrepancy was used to discriminate in-distribution (IND) from OOD samples. Performance was measured via cross-validation, holdout samples, and an independent clinical dataset. 1D-SSA was the most effective approach. In the sarcoma-IND/brain tumor-OOD setting, the framework achieved an AUROC of 0.975 and True Negative Rate (TNR)@95TPR of 0.930, and an AUROC of 0.9569 and TNR@95TPR of 0.8660 for the brain tumor-IND/sarcoma-OOD setting. On the independent clinical test set, the method yielded a mean AUROC of 0.976, a DE of 0.032, an FPR@95TPR of 0.065, and a TNR@95TPR of 0.935. These results show deep representation-based OOD detection as a practical quality-control layer for clinical-grade methylation-based tumor classification systems.

Comment
11 pages, 8 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Evaluating Single and Multi-Omics Based Explainable Artificial Intelligence (MOXAI) for Molecular Subclass Classification of Adult-Type Diffuse Gliomas

cs.CV cs.AI ·2026-09-26 ·Md Zahangir Alom, Quynh T. Tran, Breuer Alexandar, Brent A. Orr
similarity 0.70
Abstract · 8 pages, 6 figures

DNA methylation (DNAM) profiling has emerged as a powerful diagnostic tool for classifying brain and solid tumors. However, existing computational models typically analyze methylation and copy number variation (CNV) data separately, failing to capture the complementary information their integration could provide. Moreover, current classification models lack mechanisms for within-class risk assessment analogous to traditional tumor grading, and no established explainability method can attribute classification decisions to specific genomic loci. In this paper, we present MOXAI (Multi-Omics Based Explainable AI), a deep learning framework that integrates DNA methylation and copy number data from methylation arrays to classify molecular subtypes of adult-type diffuse gliomas, alongside single-modality variants for comparison. Using a cohort from The Cancer Genome Atlas (TCGA), we trained ResNet50, DINOv2, and Graph Attention Network (GAT) models on methylation data alone, copy number data alone, and combined multimodal data. We further developed explainable AI (XAI) methods based on class activation maps (CAMs) and gradient-weighted CAM (Grad-CAM) to identify the specific CpG sites, genes, and chromosomal regions most relevant to each classification decision. The multimodal model achieved up to 92.98% cross-validation accuracy, outperforming models trained on CNV data alone. DINOv2 showed the strongest generalization, reaching 94.25% accuracy (confidence >0.9) on independent validation sets. XAI results aligned with established molecular features of adult-type diffuse glioma subtypes, confirming the biological interpretability of the framework.

0.14

A Trustworthy Clinical Decision Support Framework for Brain Tumor MRI Classification: Integrating Attention-Guided Learning, Explainable AI, and Out-of-Distribution Validation

cs.CV cs.AIcs.LG ·2026-10-06 ·Arjun Kumar Gupta, Harminder Pal Monga
publishedbenchmark similarity 0.68
Abstract · Accepted for presentation at the IC3AI-2026 IEEE conference in Dec 2026. It has been accepted/selected but is not yet published. 6 pages, 4 …

Deep learning models for brain tumor diagnosis need to do more than achieve high classification accuracy. For practical use, they should also provide understandable predictions, recognize unsuitable inputs, and work within a usable clinical system. This paper presents a framework for classifying brain MRI into four categories: glioma, meningioma, pituitary tumor, and no tumor. The model uses InceptionResNetV2 with a Convolutional Block Attention Module (CBAM), while Grad-CAM provides visual explanations of its predictions. A two-stage out-of-distribution (OOD) mechanism screens unsuitable inputs using an initial grayscale check followed by Mahalanobis distance, softmax confidence, and predictive entropy. These components are brought together in NeuroScan AI, a real-time web application. Evaluated on a Mendeley brain tumor MRI dataset of 12,064 images, the framework achieved 98.70% validation accuracy, 96.73% test accuracy, and a macro-average AUC of 0.9965. The OOD pipeline achieved 99% detection accuracy on a preliminary 100-image benchmark. Grad-CAM visualizations showed qualitative correspondence with clinically established tumor locations across all four classes. Overall, the work brings classification, explainability, input validation, and deployment into one framework, while recognizing that broader clinical and OOD validation is still required.

0.25

Heterogeneity-Aware Deep Learning for Tumour Classification from Multiparametric MRI

cs.CV ·2026-08-18 ·Yue Xia, Euijoon Ahn, Tian Xia, Yuan Yuan, Michael Fulham +1 more
similarity 0.65
Abstract

Intra-tumoural heterogeneity (ITH) reflects spatial variation in tumour biology and is an important determinant of tumour behaviour, prognosis, and treatment response. Radiomics and deep learning have shown promise for tumour classification from multiparametric MRI (mp-MRI), but radiomics relies on handcrafted features, while most deep learning methods use whole-tumour representations or manually defined sub-regions, limiting scalable modelling of tumour heterogeneity. We propose a Heterogeneity-Aware Deep Learning Classification (HA-DLC) framework that explicitly models imaging-derived tumour sub-regions for lesion-type diagnosis and molecular-status prediction. HA-DLC consists of: (1) a Heterogeneous Sub-region Generation (HSG) module that produces initial pseudo-labelled sub-regions via unsupervised clustering, followed by Cross-Patient Sub-region Alignment (CPSA), which maps cluster-derived regions to a shared label space using soft assignments; and (2) a Dual-Stream Feature Extraction (DSFE) module that integrates local heterogeneity-aware features with global tumour representations. Given the initial clustering masks, CPSA, segmentation, feature extraction, and classification are jointly optimized end-to-end using soft-target segmentation and classification objectives. We evaluate HA-DLC on the LLD-MMRI2023 liver lesion dataset and the RSNA-ASNR-MICCAI 2021 Radiogenomic Brain Tumour dataset. HA-DLC consistently outperforms state-of-the-art radiomics and deep learning baselines, demonstrating the value of cross-patient sub-region alignment and dual-stream heterogeneity modelling for tumour classification from mp-MRI.

0.26

Benchmarking CNNs, Vision Transformers, and Foundation Models for Explainable Brain Tumor MRI Classification: Calibration, Decision Analysis, and External Validation

cs.CV ·2026-11-09 ·Akwasi Asare
similarity 0.64
Abstract · Under review at Scientific Report Journal, Springer

Deep learning models for brain tumor MRI classification are usually compared by accuracy alone, on public datasets whose independence is rarely checked. We benchmarked six architectures: two convolutional networks (EfficientNetV2-M and ConvNeXt-V2-Tiny), two vision transformers (Swin-V2-S and ViT-L/16), and two foundation models (DINOv2-L and MedSigLIP-448), for four-class classification of 7,216 public MRI images. We assessed accuracy, calibration, explainability, ensembles, and decision curves, with every fitted quantity estimated on validation data only. Pixel-verified duplicate screening showed that 36% of the test images had a near-duplicate in the training data. Test accuracy ranged from 94.5% to 95.6%, with no pairwise difference after Holm correction, and fell to 90.3% to 91.7% on the 773 test images free of duplicates and shared patients. Ensembles did not outperform the best single model. Attribution maps passed a model-randomization test but localized expert-annotated tumors poorly. On 1,675 external BDNeuro-MRI images that did not duplicate the training data, accuracy ranged from 77.6% (MedSigLIP-448) to 95.0% (ViT-L/16), and 12 of 15 pairwise differences were significant. Internal accuracy on this public collection therefore did not distinguish the architectures, whereas the duplicate-filtered external test did.

0.15

BrainAid: Efficient Brain Tumor Detection Using Lightweight CNNs and Explainable AI for Resource-Constrained Environments

cs.CV ·2026-10-10 ·Sai Sriram Gonthina, Ross Gore, Bikash Chandra Singh, Pronaya Bhattacharya, Sachin Shetty +2 more
similarity 0.64
Abstract

A brain tumor is an unusual growth of cells in the brain that can be cancerous or not, affecting normal brain function and causing serious risk to health. Existing solutions for brain tumor classification, such as expert manual evaluations of magnetic resonance imaging (MRI) scans, are generally inconsistent as different professionals have different criteria and can be resource-intensive, leading to delayed diagnoses. Additionally, while deep learning models have demonstrated potential, they typically require significant computational resources, motivating the need for more efficient and accessible diagnostic tools that can be deployed in real-time healthcare settings. To address these limitations, this study presents BrainAid, which makes efficient use of Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) for effective classification of four-class classification of glioma, meningioma, pituitary tumor, and no-tumor MRI scans, outperforming all the standard models such as VGG16, Inception-V3, ResNet-50 and so, while integrating Explainable AI (XAI) to improve interpretability. The BrainAid is trained to classify tumors with a high precision of 98%, achieving an F1 score of 98% and an accuracy of 98% using publicly available dataset. The model is deployed on a Raspberry Pi, demonstrating efficiency in low-resource environments. This system shows the feasibility of real-time, edge-based tumor classification, providing quick diagnostic support for medical professionals and enhancing patient care in resource-limited healthcare facilities and underserved areas.

0.07

ORB-SVM : An Innovative Hybrid Framework for Efficient Brain Tumor Detection from MRI Scans

cs.CV cs.AI ·2026-09-02 ·Amirhosein Azarpour
top venue similarity 0.62
Abstract · 6 pages , 7 figures

Brain cancer remains one of the most significant challenges in modern medicine, where the accuracy of early stage diagnosis is a decisive factor in patient survival and treatment efficacy. Although Magnetic Resonance Imaging (MRI) is the established gold standard for visualizing neurological structures, the interpretation of these high dimensional scans is often complicated by subjective variability among practitioners and the inherent noise present in complex medical images. While contemporary approaches frequently rely on high parameter deep learning architectures, such models often involve significant computational costs and require extensive data for effective training. This study introduces a hybrid framework that utilizes the Oriented FAST and Rotated BRIEF (ORB) algorithm for precise feature extraction and a Support Vector Machine (SVM) for classification [1], [2]. The proposed approach achieves a sub- stantial data reduction of approximately 99.5%, which effectively minimizes the influence of non informative background data while preserving critical diagnostic patterns essential for tumor identification. By balancing feature sparsity with a robust kernel based classifier, this methodology addresses the limitations of over parameterized systems while maintaining high diagnostic integrity. Experimental evaluations conducted on the Br35H dataset demonstrate that the framework attains a classification accuracy of 97.5%. The findings suggest that the integration of localized feature representation and optimized classification provides a reliable and resource efficient alternative for medical image analysis, offering a structured solution that maintains per- formance without the need for extensive computational overhead.

0.50

Enhanced MRI brain tumor detection using deep learning in conjunction with explainable AI SHAP based diverse and multi feature analysis

cs.CV cs.LG ·2026-11-05 ·Asif Rahman, Maqsood Hayat, Nadeem Iqbal, Fawaz Khaled Alarfaj, Salem Alkhalaf +1 more
publishedbenchmarkcode/datahighly cited similarity 0.62
Abstract · 15 pages. Published in Scientific Reports 15, 29411 (2025). Open access under CC BY 4.0

Recent innovations in medical imaging have markedly improved brain tumor identification, surpassing conventional diagnostic approaches that suffer from low resolution, radiation exposure, and limited contrast. Magnetic Resonance Imaging (MRI) is pivotal in precise and accurate tumor characterization owing to its high-resolution, non-invasive nature. This study investigates the synergy among multiple feature representation schemes such as local Binary Patterns (LBP), Gabor filters, Discrete Wavelet Transform, Fast Fourier Transform, Convolutional Neural Networks (CNN), and Gray-Level Run Length Matrix alongside five learning algorithms namely: k-nearest Neighbor, Random Forest, Support Vector Classifier (SVC), and probabilistic neural network (PNN), and CNN. Empirical findings indicate that LBP in conjunction with SVC and CNN obtained high specificity and accuracy, rendering it a promising method for MRI-based tumor diagnosis. Further to investigate the contribution of LBP, Statistical analysis chi-square and p-value tests are used to confirm the significant impact of LBP feature space for identification of brain Tumor. In addition, The SHAP analysis was used to identify the most important features in classification. In a small dataset, CNN obtained 97.8% accuracy while SVC yielded 98.06% accuracy. In subsequent analysis, a large benchmark dataset is also utilized to evaluate the performance of learning algorithms in order to investigate the generalization power of the proposed model. CNN achieves the highest accuracy of 98.9%, followed by SVC at 96.7%. These results highlight CNN's effectiveness in automated, high-precision tumor diagnosis. Code: https://github.com/asifrahman557/BrainTumorDetection

0.64

DNA Methylation Profiling in Melanoma: From Lesion Classification to Therapeutic Stratification

cs.LG q-bio.GN ·2026-08-19 ·Jana T. Winterstein, Lukas Heinlein, Günter Raddatz, Carina Nogueira Garcia, Sarah Haggenmüller +32 more
similarity 0.62
Abstract

DNA methylation provides a stable record of cellular identity, capturing epigenetic programs that distinguish specialized cell states despite a shared genome. Because malignant transformation and tumour progression are accompanied by extensive epigenetic remodeling, we hypothesized that the methylome of melanocytic lesions contains biologically and clinically relevant information for both diagnosis and disease progression. In a cohort of 1,001 tissue samples prospectively collected across eight German university hospitals profiled using Illumina Infinium MethylationEPIC arrays, we compared machine-learning models based on selected Cytosine phosphate Guanine (CpG) methylation sites with models incorporating biology-guided features, including epigenetic age acceleration, cell type composition and copy-number variation burden. In an external test set, the best diagnostic classifier was CpG-based and distinguished melanocytic nevi, noninvasive melanoma and invasive melanoma with a macro-averaged area under the receiver operating characteristic curve of 0.919 (95% CI: 0.878 to 0.952). Notably, across CpGs most strongly hyper- and hypomethylated between NV and IM, NIM showed an intermediate methylation profile, providing a molecular correlate of its diagnostic complexity. The best model for clinically relevant treatment group prediction, with AJCC stages grouped according to guideline-based management recommendations, relied on biology-guided features and achieved a macro-averaged mean absolute error of 0.627 (95% CI: 0.477 to 0.808). Together, these findings demonstrate that methylation-based models can capture both diagnostic identity and clinically relevant disease stratification, supporting DNA methylation as a promising biomarker for further validation and potential clinical translation.

0.26